A recent review highlighted how several phytochemicals can interfere with many IBD inflammatory targets, including the NF-κB pathway, thus reducing the transcription of pro-inflammatory mediators, such as interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), and interferon (IFN)-γ [18]. Here, NFKB1 is linked to inflammatory bowel disease.